 Central Nervous System Stimulants
"Central Nervous System Stimulants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.
| Descriptor ID |
D000697
|
| MeSH Number(s) |
D27.505.696.282 D27.505.954.427.220
|
| Concept/Terms |
Analeptics- Analeptics
- Analeptic Drugs
- Drugs, Analeptic
- Analeptic Agents
- Agents, Analeptic
|
Below are MeSH descriptors whose meaning is more general than "Central Nervous System Stimulants".
Below are MeSH descriptors whose meaning is more specific than "Central Nervous System Stimulants".
This graph shows the total number of publications written about "Central Nervous System Stimulants" by people in this website by year, and whether "Central Nervous System Stimulants" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 | | 1997 | 1 | 0 | 1 | | 1998 | 1 | 1 | 2 | | 1999 | 3 | 0 | 3 | | 2000 | 1 | 0 | 1 | | 2001 | 1 | 0 | 1 | | 2003 | 1 | 1 | 2 | | 2004 | 5 | 3 | 8 | | 2005 | 1 | 2 | 3 | | 2006 | 3 | 3 | 6 | | 2007 | 6 | 4 | 10 | | 2008 | 3 | 2 | 5 | | 2009 | 7 | 2 | 9 | | 2010 | 3 | 0 | 3 | | 2011 | 8 | 3 | 11 | | 2012 | 7 | 3 | 10 | | 2013 | 4 | 2 | 6 | | 2014 | 2 | 3 | 5 | | 2015 | 6 | 2 | 8 | | 2016 | 8 | 3 | 11 | | 2017 | 3 | 1 | 4 | | 2018 | 6 | 3 | 9 | | 2019 | 3 | 0 | 3 | | 2020 | 5 | 0 | 5 | | 2021 | 4 | 0 | 4 | | 2022 | 4 | 0 | 4 | | 2023 | 4 | 0 | 4 | | 2024 | 1 | 2 | 3 | | 2025 | 8 | 0 | 8 | | 2026 | 1 | 3 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Central Nervous System Stimulants" by people in Profiles.
-
Wright KP, Abbott SM, Ashbrook L, Drake CL, Flynn-Evans E, Framnes-DeBoer S, Kazmi U, Keeler K, McCall C, Morgan R, Shaffer-Hodgeman T, Trotti LM. Management of shift work disorder: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2026 Oct 24; 22(1).
-
Kim S, Sood P, Gopaul U, Mohapatra B, Mortera MH, Wen P, Heyn PC, McGowan R, Cheng Wong D, Hu X. A systematic review on pharmacotherapy of post-traumatic attention impairments. Brain Inj. 2026; 40(9):741-756.
-
Swanson CM, Wolfe JH, Calarge CA. Stimulant Medications and Bone Health. Curr Osteoporos Rep. 2026 May 14; 24(1).
-
Biernacki K, Zhai T, Hill J, McConnell E, Salmeron BJ, Kaiser RH, Janes AC. From rest to focus: pharmacological modulation of the relationship between resting state dorsal attention network dynamics and task-based brain activation. Neuropsychopharmacology. 2026 Apr; 51(5):926-933.
-
Arciniegas DB, Seel RT, Macciocchi SN, Cifu DX, Frazier YG, Kaelin DL, Katz DI, Oyesanya TO, Wagner AK. Practice Guideline for Methylphenidate Use in Persons With Traumatic Brain Injury: Report of the American Congress of Rehabilitation Medicine. Arch Phys Med Rehabil. 2026 04; 107(4):753-760.
-
McCabe DJ, Gibbs H, Falise A, Hagemann J, Kroll C, Culbreth R, Hendrickson R, Campleman S, Wax P, Brent J, Aldy K. Level of care following suspected opioid or stimulant overdose with self-harm intent. Am J Emerg Med. 2026 01; 99:264-269.
-
Strickland JC, Tilton HE, Patton NM, Vandrey R, Austin Zamarripa C, Spindle TR, Lee DC, Bergeria CL, Wolinsky D, Klawitter J, Sempio C, Campos-Palomino J, Christians U, Feldner MT, Irons JG, Bonn-Miller MO. Effect of caffeine and cannabidiol (CBD) co-administration on ?9-tetrahydrocannabinol (?9-THC) subjective effects, performance impairment, and pharmacokinetics. Neuropsychopharmacology. 2025 Nov; 50(12):1827-1835.
-
Bannett Y, Luo I, Azuero-Dajud R, Feldman HM, Brink FW, Froehlich TE, Harris HK, Kan K, Wallis KE, Whelan K, Spector L, Forrest CB. ADHD Diagnosis and Timing of Medication Initiation Among Children Aged 3 to 5 Years. JAMA Netw Open. 2025 08 01; 8(8):e2529610.
-
Falise AM, Sutphin A, Culbreth R, Aldy K, Burkhart K, Brent J, Campleman SL, Day H, Wills A, Krotulski A, Wax P. Detected substances among patients with confirmed bromazolam exposure who present to the emergency department following a suspected opioid and/or stimulant-related non-fatal overdose. Drug Alcohol Depend. 2025 Sep 01; 274:112776.
-
Cembellin-Kao A, Aldy K, Brent J, Culbreth R, LaBozzetta C, Turcios MA, Wax P, Yonamine C, Stolbach A. Occult bromazolam exposure in patients presenting with opioid or stimulant overdose. Clin Toxicol (Phila). 2025 May; 63(5):330-336.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|